Compare Quest Diagnostics Inc (DGX) vs Dicks Sporting Goods Inc (DKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Dicks Sporting Goods Inc — how do they compare? Quest Diagnostics Inc trades at $236.29 (market cap $26.24B), while Dicks Sporting Goods Inc trades at $202.61 (market cap $18.14B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and Dicks Sporting Goods Inc pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| DGX | DKS | |
|---|---|---|
Market Cap | $26.24B | $18.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $238.50 | $239.17 |
52-Week Low | $173.49 | $187.78 |
Enterprise Value | $32.00B | $24.93B |
Dividend Yield | 1.45% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $236.04, down 0.61% on the day, as the stock consolidates near recent highs following strong Q2 2026 earnings. The company has delivered three consecutive quarterly earnings beats, with Q2 EPS of $3.12 exceeding expectations by 10.6%. Revenue growth accelerated to 10.2% year-over-year, supported by strong testing demand and strategic partnerships. Technical indicators show a bullish trend with the stock trading near pivot point resistance at $238.
The outlook remains positive with raised 2026 guidance and consistent dividend payments, though valuation multiples appear full at 25.2x P/E. Key risks include margin pressure from lower-margin contracts and rising project costs. Analyst consensus leans bullish with a $249.50 price target representing 5.7% upside potential from current levels.
DKS trades at $202.66, down 1.16% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $2.90 exceeding the $2.89 estimate. Financials show solid profitability with a 4.71% net income margin and 20.9% ROE, while valuation metrics include a P/E of 19.73 and P/S of 0.92. Recent news highlights analyst upgrades and inclusion in value stock discussions.
The outlook remains positive given consistent earnings outperformance and a $263.22 consensus price target, implying 30% upside. Risks include competitive pressures and potential margin compression, but strong cash flow and bullish analyst sentiment support a favorable investment case for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →
